Novo Nordisk | NVO - أصول متداولة





أصول متداولة تغيير تاريخ
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bausch Health Companies USD 6.52B 544M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 27.35B 744M 2026-06
Novo Nordisk DKK 177.32B 4.86B 2026-03
Novo Nordisk DKK 25.71B 148.69B 2025-06
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Sanofi EUR 31.52B 1.36B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Zoetis USD 6.47B 294M 2026-03